S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study

Author:

Li Yuhong1,Qiu Miaozhen12,Xu Jianming3,Sun Guoping4,Lu Huishan5,Liu Yunpeng6,Zhong Meizuo7,Zhang Helong8,Yu Shiying9,Li Wei10,Hu Xiaohua11,Wang Jiejun12,Cheng Ying13,Zhou Juntian14,Guo Zengqing15,Guan Zhongzhen1,Xu Ruihua1

Affiliation:

1. Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

2. Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

3. Department of Oncology, 307 Hospital of the People's Liberation Army, Beijing, China

4. Department of Oncology, The First Affiliated Hospital of AnHui Medical University, Hefei, China

5. Department of General Surgery, Affiliated Union Hospital, Fujian Medical University, Fuzhou, China

6. The Second Lab of Cancer Research Institute, The First Hospital of China Medical University, Shenyang, China

7. Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China

8. Department of Oncology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China

9. Department of Oncology, Tongji Cancer Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

10. Stem Cell and Cancer Center, First Affiliated Hospital, Jilin University, Changchun, Jilin, China

11. Department of Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China

12. Department of Oncology, Changzheng Hospital, Shanghai, China

13. Department of Oncology, Tumor Hospital of Jilin Province, Changchun, China

14. Department of Oncology, Tumor Hospital of Hunan Province, Changsha, China

15. Department of Oncology, Tumor Hospital of Fujian Province, Fuzhou, China

Publisher

Impact Journals, LLC

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3